BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belizaire R, Makar RS. Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion. Transfus Med Rev 2020;34:242-9. [PMID: 33129606 DOI: 10.1016/j.tmrv.2020.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Song X, Qi J, Fang K, Li X, Han Y. A meta-analysis of risk factors associated with platelet transfusion refractoriness. Int J Hematol 2023. [PMID: 36856992 DOI: 10.1007/s12185-023-03557-3] [Reference Citation Analysis]
2 Wang J, You X, He Y, Hong X, He J, Tao S, Zhu F. Simultaneous genotyping for human platelet antigen systems and HLA-A and HLA-B loci by targeted next-generation sequencing. Front Immunol 2022;13:945994. [DOI: 10.3389/fimmu.2022.945994] [Reference Citation Analysis]
3 Ansari AM, Khorasanchi A, Faghihimehr A, Toor A. Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia. Clin Case Rep 2021;9:e04788. [PMID: 34659753 DOI: 10.1002/ccr3.4788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Smethurst P, Cardigan R. Current challenges in platelet transfusion. Platelets 2021;:1-10. [PMID: 34392769 DOI: 10.1080/09537104.2021.1961711] [Reference Citation Analysis]
5 Lombard FW, Popescu WM, Oprea AD, Kertai MD. Perioperative thrombocytopenia. Curr Opin Anaesthesiol 2021;34:335-44. [PMID: 33935182 DOI: 10.1097/ACO.0000000000000999] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]